Home › Glioma › Florida › Miami

Pag-aaral pangklinika para sa Glioma sa Miami, FL

Isang pag-aaral para sa Glioma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Miami. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

Nagre-recruitPhase 1/2

University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami

12 Months – 21 Years · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT05099003

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

Nagre-recruitPhase 2

Miami Cancer Institute, Miami

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07326566

ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas

Nagre-recruitPhase 2

Nicklaus Children's Hospital, Miami

12 Months – 39 Years · Lahat ng kasarian · Na-update Set 21, 2026 · NCT06838676

Targeted Pediatric High-Grade Glioma Therapy

Nagre-recruitObservasyonal na pag-aaral

University of Miami, Miami

12 Months – 39 Years · Lahat ng kasarian · Na-update Set 8, 2026 · NCT05839379

Study of Olutasidenib and Temozolomide in HGG

Nagre-recruitPhase 2

University of Miami Hospital and Clinics, Miami

Edad 12 hanggang 39 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT06161974

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

Nagre-recruitPhase 3

University of Miami Health, Miami

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT05303519

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

Nagre-recruitPhase 2

Nicklaus Children's Hospital, Miami

Edad 3 hanggang 39 · Lahat ng kasarian · Na-update Ago 24, 2026 · NCT05096481

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

Nagre-recruitPhase 2

University of Miami Hospital and Clinics, Miami

Edad 8 pataas · Lahat ng kasarian · Na-update Hul 27, 2026 · NCT05503797

Pembrolizumab, Olaparib, and Temozolomide for People With Glioma

Nagre-recruitPhase 2

BAPTIST ALLIANCE - MCI (Data Collection Only), Miami

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 22, 2026 · NCT05188508

STARLITE for Unresectable High-Grade Gliomas

Nagre-recruitPhase 1

University of Miami, Miami

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 25, 2026 · NCT06428045

PrOton Pulsed reduCed dOse Rate Radiotherapy for Recurrent CNS maligNancies Trial

Nagre-recruit

Miami Cancer Institute at Baptist Health, Inc., Miami

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 1, 2026 · NCT06397560

DB107-Retroviral Replicating Vector (RRV) Combined With DB107-Flucytosine (FC) in Patients With Recurrent Glioblastoma or Anaplastic Astrocytoma

Nagre-recruitPhase 2

University of Miami Hospital, Miami

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update May 28, 2026 · NCT06264388

Non-invasive Glioma Characterization Through Molecular Imaging

Nagre-recruit

University of Miami, Miami

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 20, 2026 · NCT03684109

DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Glioma

Nagre-recruitPhase 1/2

University of Miami, Miami

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 11, 2026 · NCT06504381

Study of LAM561 Acid in Pediatric Patients With Malignant Glioma and Other Advanced Solid Tumors

Nagre-recruitPhase 1/2

University of Miami Hospital, Miami

Hanggang edad 18 · Lahat ng kasarian · Na-update Nob 20, 2025 · NCT04299191

Pag-aaral para sa Glioma sa ibang lungsod

Iba pang pag-aaral sa Miami

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.